Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Stock Short Interest Report for October

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the recipient of a significant decline in short interest in the month of October. As of October 30th, there was short interest totaling 2 shares, a decline of 99.5% from the October 15th total of 423 shares. Based on an average daily volume of 457 shares, the days-to-cover ratio is currently 0.0 days.

Hikma Pharmaceuticals Stock Performance

OTCMKTS:HKMPY remained flat at $47.75 during trading hours on Thursday. 46 shares of the company’s stock traded hands, compared to its average volume of 1,176. The firm has a 50 day moving average price of $43.66 and a 200 day moving average price of $40.79. Hikma Pharmaceuticals has a 1 year low of $31.80 and a 1 year high of $47.75.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals plc is a multinational pharmaceutical company that develops, manufactures and markets a broad range of medicines. Its portfolio includes generic, branded and specialty pharmaceutical products, as well as injectable medicines used in hospitals and other healthcare settings. The company serves healthcare providers, pharmacies and patients across the United States, Europe, the Middle East and North Africa, and other international markets. Its products cover a variety of therapeutic areas, with operations spanning prescription medicines, hospital injectables and established branded treatments.